Abstract
https://ir.ptcbio.com/static-files/b06f07d0-248f-404a-9041-2ec5aff2abce
1 clinical trial
2 products
2 drugs
1 indication
Clinical trial
A Phase 2A, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of PTC518 in Subjects With Huntington's DiseaseStatus: Recruiting, Estimated PCD: 2024-03-31
Indication
Huntington's diseaseProduct
PlaceboProduct
PTC518Drug
PTC518Drug
placebo